Navigation Links
Consider Weight When Choosing Blood Pressure Meds: Study
Date:12/6/2012

By Steven Reinberg
HealthDay Reporter

THURSDAY, Dec. 6 (HealthDay News) -- Taking a patient's weight into account when choosing blood pressure medications might help prevent strokes, heart attacks and death, a new study suggests.

Lean and obese people react differently to different blood pressure medications, said the researchers, who believe their findings could change the way high blood pressure (hypertension) is treated.

"Unexpectedly, people who have high blood pressure and are fat actually have a better prognosis than people who have high blood pressure and are thin," said lead researcher Dr. Michael Weber, a professor of medicine at Downstate Medical Center of the State University of New York in New York City.

"You can now choose blood pressure medication as a means of compensating for this difference between obese and thin people, so that it's possible to treat everybody with a medicine that maximizes the outcome regardless of how much you weigh," he said.

Weber recommends starting all patients with high blood pressure on a class of drugs called calcium channel blockers, regardless of weight. One such drug is Norvasc (amlodipine).

Although diuretics, which reduce excess water in the body, are effective in obese patients, they can harm thin patients, and should be relegated to a third-line therapy, Weber said.

Obese people respond better to diuretics, Weber explained, because their hypertension is often caused by a combination of excess weight, too much fluid and too much salt. Thin hypertensive patients, he said, may have underlying circulatory problems that are causing their high blood pressure and placing them at increased risk for cardiovascular disease.

For the study, published in the Dec. 6 online edition of The Lancet, Weber's group analyzed data on more than 11,000 individuals in an international high blood pressure trial.

That trial compared treatment with
'/>"/>

Copyright©2012 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. FDA Panel to Consider At-Home HIV Test
2. Medical Tourism: Uncharted Territory for Patients James Goldberg, Author of the American Medical Money Machine, Is Offering a New Consulting Service to Medical Patients Considering “Medical Tourism” Treatment
3. Workplace bullying witnesses consider quitting more than the victims: UBC study
4. Abiraterone: Indication of considerable added benefit in certain patients
5. Considerably more patients may benefit from effective antidiabetic drug
6. When considering bariatric surgery think about bones
7. Considerable added benefit of ipilimumab in advanced melanoma
8. Policy considerations pose options for leaders to reduce costly disparities in diabetes
9. Tamoxifen trial should prompt breast cancer patients to reconsider treatment options
10. Tree nut consumption associated with lower body weight and lower prevalence of health risks
11. Even Preschoolers View the Overweight Negatively
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Consider Weight When Choosing Blood Pressure Meds: Study
(Date:7/31/2015)... New York (PRWEB) , ... ... ... trial attorney Jason T. Brown’s live lecture on pharmaceutical negligence is now ... 28th, 2015 was well received with a 94% approval rating from the ...
(Date:7/31/2015)... VA (PRWEB) , ... July 31, 2015 , ... ... is a one-day event geared to patients and family members, medical professionals, and ... and regional mesothelioma experts. The conference is a collaborative effort between the Mesothelioma ...
(Date:7/31/2015)... ... July 31, 2015 , ... “Engage: Don’t Just Age” will ... thought leadership symposiums, hosted by Massachusetts-based Harmony Healthcare International at Foxwoods Resort ... 250 “C”-level executives, administrators, directors of nursing, rehabilitation managers and other management and ...
(Date:7/31/2015)... ... ... The Mount Sinai Health System will work with Columbia Care LLC, a ... treatments. The collaboration moves into the next phase with the recent decision by the ... licenses to produce and dispense medical marijuana. , Mount Sinai and Columbia Care ...
(Date:7/31/2015)... ... 2015 , ... Like nearly every other form of surgery, it shouldn't come ... effective and less intrusive and painful. Leading these advances in the United States ... currently stands as the only doctor in the United States who is qualified to ...
Breaking Medicine News(10 mins):Health News:Re-Broadcast of Nationally Renowned Trial Attorney Jason T. Brown's Lecture on Pharmaceutical Negligence Now Available 2Health News:New York Area Mesothelioma Specialists to Present at Conference 2Health News:New York Area Mesothelioma Specialists to Present at Conference 3Health News:Harmony Healthcare International Announces Speaker Line-up for “HARMONY 2015” 2Health News:Harmony Healthcare International Announces Speaker Line-up for “HARMONY 2015” 3Health News:Mount Sinai to Collaborate with Columbia Care on Medical Marijuana Research 2Health News:Mount Sinai to Collaborate with Columbia Care on Medical Marijuana Research 3Health News:Loria Medical Penile Enlargement Center to Expand, Offering Practice Partnership to Doctors 2
... Better understanding of genetic, biological causes could lead more ... (HealthDay News) -- When people understand the genetics and ... blame those with the eating disorder for their illness, ... (UNC) study. , "This is a potentially important ...
... of women showed effect lasted long after program ended ... exercises can help relieve chronic neck pain, says a ... Care & Research . , Previous studies have produced ... pain, but there hasn,t been enough high-quality research to ...
... immune system should fight tumors, researchers say , , ... to fight ovarian and breast cancer are in ... their safety and effectiveness, researchers report. , The ... Coukos, an assistant professor at the University of ...
... The state,s most highly-respected minds in medicine and emergency ... to improve Missouri,s emergency response systems, JEFFERSON CITY, ... will meet Tuesday, January 15, 2008, to compile,recommendations for ... the mortality and morbidity associated with stroke and ST-Segment,Elevation ...
... With a continued focus on,quality and ... to focus on opportunities for streamlining processes ... functions for,manufacturing organizations, the majority of the ... centralization could provide several,worthwhile benefits, as found ...
... for Collective Bargaining, ,Prompt Pay,Legislation, WASHINGTON, Jan. ... of Inspector General (OIG) on independent pharmacy payments ... Hill and runs counter to,claims from the independent ... today., "This report will raise eyebrows among ...
Cached Medicine News:Health News:Science Could Erase Stigma of Anorexia 2Health News:Strength Training Eases Chronic Neck Pain 2Health News:Vaccines for Ovarian and Breast Cancer in Early Trials 2Health News:Vaccines for Ovarian and Breast Cancer in Early Trials 3Health News:Time Critical Diagnosis Task Force Convenes in Jefferson City 2Health News:Manufacturing Organizations Identify Efficiencies in Maintenance Functions 2Health News:PCMA: New Study on Independent Pharmacy Reimbursements Will 'Raise Eyebrows' on Capitol Hill 2
(Date:7/30/2015)... July 30, 2015 PTC Therapeutics, Inc. (NASDAQ: ... reported financial results for the second quarter ending June ... many fronts across the organization.  We are excited to ... dystrophy clinical trial ever conducted with topline results expected ... Chief Executive Officer, PTC Therapeutics, Inc. "Translarna is now ...
(Date:7/30/2015)... WOODCLIFF LAKE, N.J. , July 30, 2015 /PRNewswire/ ... submitted simultaneously in the United States ... (to the FDA, EMA and MHLW, respectively) for eribulin, ... sarcoma (STS) who have received prior chemotherapy for advanced ... are based on data from a pivotal global Phase ...
(Date:7/30/2015)... FAIRFIELD, N.J. , July 30, 2015 /PRNewswire/ ... Ferrer, completed the second Phase III clinical study ... development for impetigo.  Medimetriks owns the exclusive U.S. ... The global trial, conducted at 44 centers with ... and pediatric patients aged 2 months and older ...
Breaking Medicine Technology:PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 2PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 3PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 4PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 5PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 6PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 7PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 8PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 9PTC Therapeutics Reports Second Quarter 2015 Financial Results and Provides Corporate Update 10Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 2Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 3Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 4Eisai Submits Simultaneous Regulatory Applications for Eribulin in Soft Tissue Sarcoma in the United States, European Union and Japan 5Medimetriks Pharmaceuticals, Inc. Announces Completion of the Second Successful Pivotal Phase III Study for Ozenoxacin 2Medimetriks Pharmaceuticals, Inc. Announces Completion of the Second Successful Pivotal Phase III Study for Ozenoxacin 3
... Voreloxin Demonstrates Promising Clinical Activity in Patients with ... Difficult-to-Treat ... Sunesis,Pharmaceuticals, Inc. (Nasdaq: SNSS ) presented data from three ... the Chemotherapy Foundation Symposium held in New York on November ...
... 5 Medarex, Inc.,(Nasdaq: MEDX ) today ... of,an undisclosed amount from its licensing partner, Centocor ... trial of CNTO 95, a fully human antibody,targeting ... The CNTO 95 human antibody was generated using ...
Cached Medicine Technology:Sunesis Pharmaceuticals Presents Clinical Trial Data of Voreloxin in Patients with Acute Myeloid Leukemia and Ovarian Cancer at the Chemotherapy Foundation Symposium 2Sunesis Pharmaceuticals Presents Clinical Trial Data of Voreloxin in Patients with Acute Myeloid Leukemia and Ovarian Cancer at the Chemotherapy Foundation Symposium 3Sunesis Pharmaceuticals Presents Clinical Trial Data of Voreloxin in Patients with Acute Myeloid Leukemia and Ovarian Cancer at the Chemotherapy Foundation Symposium 4Sunesis Pharmaceuticals Presents Clinical Trial Data of Voreloxin in Patients with Acute Myeloid Leukemia and Ovarian Cancer at the Chemotherapy Foundation Symposium 5Medarex Receives Milestone Payment for Investigational Antibody Targeting Integrin Receptors 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: